BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Treatment
45945 results:

  • 1. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma.
    Zhao H; Meng L; Du P; Liao X; Mo X; Gong M; Chen J; Liao Y
    Biol Res; 2024 May; 57(1):30. PubMed ID: 38760850
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
    Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
    J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
    Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
    Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
    Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
    PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. METTL8 links mt-tRNA m
    Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
    Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic nomogram in middle-aged and elderly patients with chordoma: A SEER-based study.
    Ouyang C; Sun Y; Li Y; Jiang M; Nong L; Gao G
    J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254208. PubMed ID: 38744697
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
    Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
    Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [A rare cause of hypercorticism: ACTH-secreting pheochromocytoma (a case report)].
    Rifai K; Toulali F; Iraqi H; Ettaik M; Gharbi MEH
    Pan Afr Med J; 2024; 47():88. PubMed ID: 38737225
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. In Vitro and In Vivo Studies of Melanoma cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM.
    Pompili SVB; Fanzini S; Schachner M; Chen S
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732030
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.
    Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Repeat Radiosurgery for Sporadic Vestibular Schwannoma After Primary Radiosurgical Failure: An International Multi-institutional Investigation.
    Khandalavala KR; Herberg HA; Kay-Rivest E; Moore LS; Yancey KL; Marinelli JP; Lund-Johansen M; Kosaraju N; Lohse CM; Kutz W; Santa Maria PL; Golfinos JG; Kondziolka D; Carlson ML; Tveiten ØV; Link MJ
    Otol Neurotol; 2024 Jun; 45(5):587-593. PubMed ID: 38728563
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma cells to TRAIL-Mediated Apoptosis.
    Kuranaga Y; Yu B; Osuka S; Zhang H; Devi NS; Bae S; Van Meir EG
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727288
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A Roadmap of CAR-T-cell Therapy in Glioblastoma: Challenges and Future Perspectives.
    Montoya M; Gallus M; Phyu S; Haegelin J; de Groot J; Okada H
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727262
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study.
    Mordoh J; Schwab E; Bravo AI; Aris M; Barrio MM
    Front Immunol; 2024; 15():1354710. PubMed ID: 38726010
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin-induced apoptosis of melanoma cells.
    Bian F; Niu FH; Qu PY; Gong F; Yan JZ
    Chem Biol Drug Des; 2024 May; 103(5):e14536. PubMed ID: 38725079
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Glioma.
    Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
    Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2298.